Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Open Access

Correction

Correction: MPT0B169, a New Antitubulin Agent, Inhibits Bcr-Abl Expression and Induces Mitochondrion-Mediated Apoptosis in Nonresistant and Imatinib-Resistant Chronic Myeloid Leukemia Cells

  • Shuit-Mun Wong,
  • Fu-Hwa Liu,
  • Yueh-Lun Lee,
  • Huei-Mei Huang
  • Article
  • Metrics
  • Comments
  • Media Coverage

The affiliation for the third author is incorrect. Yueh-Lun Lee is affiliated with: Department of Microbiology and Immunology, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.

Reference

  1. 1. Wong S-M, Liu F-H, Lee Y-L, Huang H-M (2016) MPT0B169, a New Antitubulin Agent, Inhibits Bcr-Abl Expression and Induces Mitochondrion-Mediated Apoptosis in Nonresistant and Imatinib-Resistant Chronic Myeloid Leukemia Cells. PLoS ONE 11(1): e0148093. https://doi.org/10.1371/journal.pone.0148093 pmid:26815740

Citation: Wong S-M, Liu F-H, Lee Y-L, Huang H-M (2017) Correction: MPT0B169, a New Antitubulin Agent, Inhibits Bcr-Abl Expression and Induces Mitochondrion-Mediated Apoptosis in Nonresistant and Imatinib-Resistant Chronic Myeloid Leukemia Cells. PLoS ONE 12(10): e0186531. https://doi.org/10.1371/journal.pone.0186531

Published: October 11, 2017

Copyright: © 2017 Wong et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.